News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TomoTherapy Announces Strategic Alliance with PTW



10/17/2007 11:28:41 PM

MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TTPY), developer of the TomoTherapy® Hi·Art® treatment system for helical intensity-modulated radiation therapy (IMRT), announced today a strategic alliance with PTW, provider of advanced dosimetry and quality assurance equipment for radiation therapy. The alliance will enable TomoTherapy treatment centers worldwide to verify patient-specific treatment plans with added convenience and efficiency. “This is another important step for us,” said Peter Hoban, senior product manager for TomoTherapy Incorporated. “PTW is an innovative company, providing state-of-the-art quality assurance equipment. This alliance helps TomoTherapy add QA options and workflow enhancements to our integrated platform.”

Read at BioSpace.com


comments powered by Disqus
PTW
TomoTherapy
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES